Show simple item record

Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules

dc.contributor.authorGregory, Paula E.en_US
dc.contributor.authorGutmann, David H.en_US
dc.contributor.authorMitchell, Anna L.en_US
dc.contributor.authorPark, Soochulen_US
dc.contributor.authorBoguski, Marken_US
dc.contributor.authorJacks, Tyleren_US
dc.contributor.authorWood, Deborah L.en_US
dc.contributor.authorJove, Richarden_US
dc.contributor.authorCollins, Francis S.en_US
dc.date.accessioned2006-09-11T16:11:09Z
dc.date.available2006-09-11T16:11:09Z
dc.date.issued1993-05en_US
dc.identifier.citationGregory, Paula E.; Gutmann, David H.; Mitchell, Anna; Park, Soochul; Boguski, Mark; Jacks, Tyler; Wood, Deborah L.; Jove, Richard; Collins, Francis S.; (1993). "Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules." Somatic Cell and Molecular Genetics 19(3): 265-274. <http://hdl.handle.net/2027.42/45544>en_US
dc.identifier.issn0740-7750en_US
dc.identifier.issn1572-9931en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/45544
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8332934&dopt=citationen_US
dc.description.abstractThe neurofibromatosis type 1 (NF1) gene was recently identified by positional cloning and found to encode a protein with structural and functional homology to mammalian and yeast GTPase-activating proteins (GAPs). Using antibodies directed against the NF1 gene product, a protein of ∼250kDa was identified and termed neurofibromin. Double-indirect immunofluorescent labeling with anti-neurofibromin and anti-tubulin antibodies demonstrates that neurofibromin associates with cytoplasmic microtubules. Immunoblotting of microtubule-enriched cytoplasmic fractions, using antibodies generated against neurofibromin, shows that neurofibromin copurifies with microtubules. When portions of neurofibromin are expressed in Sf9 insect cells they associate with polymerized microtubules; furthermore, the critical residues for this interaction reside within the GAP-related domain of neurofibromin. The unexpected association of neurofibromin with microtubules suggests that neurofibromin is involved in microtubule-mediated intracellullar signal transduction pathways.en_US
dc.format.extent1053449 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherBiomedicineen_US
dc.subject.otherAnimal Anatomy / Morphology / Histologyen_US
dc.subject.otherHuman Geneticsen_US
dc.subject.otherPlant Sciencesen_US
dc.titleNeurofibromatosis type 1 gene product (neurofibromin) associates with microtubulesen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelNatural Resources and Environmenten_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbsecondlevelEcology and Evolutionary Biologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumThe Departments of Internal Medicine, Human Genetics, Neurology and Microbiology and Immunology, The University of Michigan Medical Center and The Howard Hughes Medical Institute, The University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumThe Departments of Internal Medicine, Human Genetics, Neurology and Microbiology and Immunology, The University of Michigan Medical Center and The Howard Hughes Medical Institute, The University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumThe Departments of Internal Medicine, Human Genetics, Neurology and Microbiology and Immunology, The University of Michigan Medical Center and The Howard Hughes Medical Institute, The University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumThe Departments of Internal Medicine, Human Genetics, Neurology and Microbiology and Immunology, The University of Michigan Medical Center and The Howard Hughes Medical Institute, The University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumThe Departments of Internal Medicine, Human Genetics, Neurology and Microbiology and Immunology, The University of Michigan Medical Center and The Howard Hughes Medical Institute, The University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumThe Departments of Internal Medicine, Human Genetics, Neurology and Microbiology and Immunology, The University of Michigan Medical Center and The Howard Hughes Medical Institute, The University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationumThe Departments of Internal Medicine, Human Genetics, Neurology and Microbiology and Immunology, The University of Michigan Medical Center and The Howard Hughes Medical Institute, The University of Michigan, 48109, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherCenter for Cancer Research, Massachusetts Institute of Technology, 40 Ames Street, 02139, Cambridge, Massachusettsen_US
dc.contributor.affiliationotherNational Center for Biotechnology Information, NIH, 20894, Bethesda, Marylanden_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid8332934en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/45544/1/11188_2005_Article_BF01233074.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF01233074en_US
dc.identifier.sourceSomatic Cell and Molecular Geneticsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.